Infamous ex-pharma CEO Martin Shkreli weighs in on EpiPen price hike

Several members of Congress are demanding to know why the price of EpiPens has skyrocketed by 500 percent. The devices deliver a life-saving injection for people with severe allergies. Vinita Nair spoke with a former pharmaceutical exec who faced similar criticism last year. Source